Table A2.

Parkinson’s disease patients’ medication and LEDD scores.

Patient Number	Medication (mg)	LEDD
1	Pramipexole 3.15	450
2	Pramipexole 0.52, Rasagiline 1	175
3	Pramipexole 3.15, L-Dopa 300, C-L-Dopa 100	825
4	L-Dopa 400, Amantadine 200, Rasagiline 1, Rotigotine 12	1060
5	L-Dopa 1000, Entecapone 1000, Pramipexole 1.75, Oral Selegiline 10	1680
6	L-Dopa 400	400
7	L-Dopa 600, Entecapone 600, Pramipexole 1.04	948
8	L-Dopa 350, C-L-Dopa 500, Pramipexole 2.1	1025
9	L-Dopa 400, Rotigotine 2	460
10	L-Dopa 550, Rotigotine 16, Rasagiline 1, Amantadine 200	1330
11	L-Dopa 600, Amantadine 200, Rotigotine 6, Cabergoline 6	1380
12	L-Dopa 600, C-L-Dopa 100, Entecapone 1200, Pramipexole 1.57	1098
13	L-Dopa 600, C-L-Dopa 300, Entecapone 800, Cabergoline 6	1497
14	L-Dopa 700, C-L-Dopa 100, Entecapone 600, Rotigotine 8	1246
15	L-Dopa 500, Piribidil 50	550
16	L-Dopa 600, Entecapone 800	798

LEDD = Levodopa Equivalent Daily Dosage (mg per day) [102]; C-L-Dopa = Controlled-Release L-Dopa; Pramipexole was reported as base form dosis. For computation of LEDD scores, the salt form was used (Pramipexole dihydrochloride 1 H₂O) [102].